$INSY A slow and, so far, steady climb back UP in share price climb. Despite some negative Press, Insys Therapeutics maintains a positive direction by its focus on addressing issues caused by the litigations AND development & approvals for new medications.
Everyone is aware of the dark clouds that hover over Insys Therapeutics. Some see the storm as a negative. I see the clouds producing rain that nourishes. Bad times? Maybe! GOOD TIMES? Yes! Future Growth? Hell yes!!!!
(0)
(0)
Insys Therapeutics Inc. (INSYQ) Stock Research Links